Avonex Sales Data

Rank 48 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Avonex U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 48 (3) -1.43% -6.67%
Q3 2013 45 (4) -6.68% -14.77%
Q2 2013 41 (2) -9.51% -9.28%
Q1 2013 39 (6) -9.05% -13.39%
Q4 2012 33 (4) -5.17% -8.94%
Q3 2012 29 (4) -5.34% -6.82%
Q2 2012 33 (6) 6.61% 1.54%
Q1 2012 39 (1) 2.22% -3.70%
Q4 2011 38 (5) 0.19% -2.17%
Q3 2011 33 -0.05% -1.43%
Q2 2011 33 (4) 2.45% -1.41%
Q1 2011 37

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
May 14, 2012New Avonex Dosing Innovations for People with Multiple Sclerosis Now Available in US

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web2)